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Abstract 10 
Biosensors are biological molecules able to detect and report the presence of a target molecule by the 11 
emission of a signal. Nucleic acids are particularly appealing for the design of such molecule since 12 
their great structural plasticity makes them able to specifically interact with a wide range of ligands 13 
and their structure can rearrange upon recognition to trigger a reporting event. A biosensor is typically 14 
made of three main domains: a sensing domain that is connected to a reporting domain via a 15 
communication module in charge of transmitting the sensing event through the molecule. The 16 
communication module is therefore an instrumental element of the sensor. This module is usually 17 
empirically developed through a trial-and-error strategy with the testing of only a few combinations 18 
judged relevant by the experimenter. In this work, we introduce a novel method combining the use of 19 
droplet-based microfluidics and next generation sequencing. This method allows to functionally 20 
characterize up to a million of different sequences in a single set of experiments and, by doing so, to 21 
exhaustively test every possible sequence permutations of the communication module. Here, we 22 
demonstrate the efficiency of the approach by isolating a set of optimized RNA biosensors able to 23 
sense theophylline and to convert this recognition into fluorescence emission. 24 
 25 
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1. Introduction 1 
Structure-switching aptamers hold great promise for the conception of biosensors aiming at 2 
detecting small molecules (e.g. metabolites, chemicals) or biological polymers (e.g. proteins) with 3 
applications ranging from bio-surveillance to gene expression monitoring [1, 2]. A typical allosteric 4 
biosensor is made of a sensing domain that specifically recognizes a target molecule and transmits the 5 
information, via a communication module (CM), to an effector domain reporting the sensing event [3]. 6 
Nucleic acids are particularly interesting for the development of such sensors since they are cheap to 7 
produce in large scale by chemical synthesis, they can easily be expressed in living cells, specific 8 
sensing aptamers can be rapidly identified using SELEX in vitro selection processes [4, 5] and their 9 
engineering is greatly facilitated by the existence of structure prediction algorithms [6, 7]. The 10 
reporting domain can consist of a catalytic moiety [3] or another domain that converts the sensing 11 
event into an electrochemical, luminescent or fluorescent signal [8].  12 
Light-up RNA aptamers constitute a new appealing class of reporting domain. These RNAs are 13 
nucleic acid scaffolds able to specifically recognize and activate the fluorescence of small fluorogenic 14 
molecules (also called fluorogens) that are poorly emissive in their free state but become highly 15 
fluorescent upon complex formation [9, 10]. Many aptamers (e.g. MG [11], Spinach [12], Mango [13], 16 
DIR2s [14]) able to specifically activate the fluorescence of their cognate fluorogen (Malachite green, 17 
3,5-difluoro-4-hydroxybenzylidene imidazolinone (DFHBI), Thiazole Orange 1-biotin and 18 
dimethylindole red (DIR) respectively) have been developed over the past decade. The crystal 19 
structure of most of these aptamer/fluorogen complexes has also been determined [15-21], making 20 
possible to further engineer the aptamer by rational design. For instance, weakening the stability of a 21 
key structural element (e.g. a helix located close to the fluorogen-binding site) can be used to suppress 22 
the capacity of the aptamer to interact with its fluorogen. However, this inactivation can be 23 
conditionally restored by connecting the destabilized aptamer to a structure-switching aptamer acting 24 
as a sensing domain. In this scheme, target detection by the sensing aptamer should lead to a structural 25 
switching transmitted to the light-up aptamer that recovers its capacity to form a fluorescent complex 26 
with its fluorogen (Fig. 1A). The communication module (CM) is the instrumental element of such a 27 
molecule since high fluorescence should be emitted only in the presence of the target whereas 28 
background fluorescence should be kept as low as possible. CM are usually empirically developed 29 
through a trial-and-error strategy and their design would strongly benefits from ultrahigh-throughput 30 
screening technologies [22].  31 
In this work, we combined the use of droplet-based microfluidic screening platforms with Next 32 
Generation Sequencing (NGS) to devise an ultrahigh-throughput analytical pipeline allowing for 33 
efficiently and exhaustively screening large RNA libraries while minimizing the labor-intensive and 34 
time-consuming post-screening analysis work. We demonstrate the efficiency of this method by 35 
developing a theophylline fluorogenic biosensor in which a theophylline-binding aptamer is linked to 36 
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a light-up RNA aptamer by an optimized CM allowing efficient extinction of the probe in the absence 1 
of target, whereas the construct becomes brighter than the parental light-up aptamer in the presence of 2 
the theophylline. 3 
 4 
2. Material and methods 5 
2.1. Reagents 6 
Theophylline, caffeine, and guanine were purchased from Sigma-Aldrich and the corresponding 7 
solution were prepared at 20 mM in DEPC-treated water (Roth) or HCl for guanine. 10 mM c-diGMP 8 
(Sigma-Aldrich) solution was prepared in water and 32 mM S-adenosylmethionine (SAM) solution 9 
was obtained from New England Biolabs. 10 
2.2. Preparation of the biosensor library 11 
The library (Fig. S1) was designed using iSpinach [23] as starting point. A double mutant of the 12 
aptamer was fused to theophylline aptamer via 2 stretches of 4 randomized residues. The 13 
corresponding iSpinachUA-lib-Theo template (5’-14 
GCGACTACGGTGAGGGTCGGGTTNNNNataccagccgaaaggcccttggcagNNNNTTAAGTAGAGTG15 
TGGGCTCCGTAGTCGC-3’, with the randomized positions bolded, the mutations introduced in 16 
iSpinach underlined and theophylline aptamer shown in lower case) was ordered from Integrated DNA 17 
Technologies using “hand-mixing” option to adjust the insertion rate of each nucleotide to 25%. 18 
Constant regions and T7 RNA polymerase promoter were added by PCR by mixing 2 nM of 19 
iSpinachUA-lib-Theo template diluted into 200 g/mL yeast total RNA solution (Ambion), 0.2 M of 20 
Fwd-add-ExtiSpi (5’-21 
GCTAATACGACTCACTATAGGAAGACGTAGCAAGGCGACTACGGTGAGGGTCGGG-3’, with 22 
the constant region underlined and the T7 RNA polymerase promoter italicized), 0.2 M of Rev-add-23 
ExtiSpi (5’-TGTGTTCTCTGTCATCTCTCTGGCGACTACGGAGCCCACACTC-3’, with the 24 
constant region underlined), 0.2 mM of each dNTPs (Fermentas), 2 units (U) of Q5 DNA polymerase 25 
(New England Biolabs) and the corresponding buffer at recommended concentration.  26 
Critical points:  27 
- throughout the procedure, the addition of yeast total RNA is highly recommended to 28 
prevent the loss of DNA by adsorption on tube walls. 29 
- ordering the template DNA using an ‘hand-mixing’ option is of prime importance here to 30 
limit important sequence biases that may occur in solid-phase synthesis and that may 31 
challenge the proper coverage of the library during the screening step 32 
 33 
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The PCR mixture was thermocycled starting with an initial denaturation step of 30 seconds at 95 1 
°C followed by 25 repeats of the two-step cycle: 95 °C for 5 seconds and 60 °C for 30 seconds.  PCR 2 
products were purified using "Wizard® SV Gel and PCR Clean-up System " kit (Promega).  3 
2.3. Unique Droplet Identifier addition 4 
A Unique Droplet Identifier (UDI) was appended to each DNA molecule of the library by 5 
introducing 1 pmol of the iSpinachUA-lib-Theo template extended by constant regions in 100 L of 6 
PCR mixture containing 0.2 M of Bracode-T7 primer (5’- 7 
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGAANNNNNNNNNNNNNNNNNNNNAAT8 
ATCTAATACGACTCACTATAGGAAGACGTAGCAAG -3’ with the UDI sequence bolded, the T7 9 
RNA polymerase promoter italicized and the sequence complementary to iSpinachUA-lib-Theo 10 
template underlined) and 0.2 M of Rev-add-ExtiSpi primer (see above), 0.2 mM of each dNTPs 11 
(Fermentas), 2 U of Q5 DNA polymerase (New England Biolabs) and the corresponding buffer at the 12 
recommended dilution.  13 
The PCR mixture was thermocycled starting with an initial denaturation step of 1 minute at 98°C 14 
followed by 30 cycles of: 10 seconds at 98°C, 30 seconds at 55°C and 30 seconds at 72°C, and the 15 
PCR products were purified using a “Wizard® SV Gel and PCR Clean-up System " kit (Promega). 16 
Upon PCR amplification, an aliquot of this amplification mixture was introduced into a fresh one of 17 
similar composition but containing 0.2 M of Fwd-AmpliBarcode (5’-18 
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG-3’) and Rev-add-ExtiSpi primers instead. 19 
PCR products were again purified using a "Wizard® SV Gel and PCR Clean-up System " kit 20 
(Promega). Note that all the PCR amplification mixtures used during this work were prepared using a 21 
laminar flow PCR hood (Captair®Bio by Erlarb) isolated in a dedicated room to prevent 22 
contaminations. 23 
Critical point: The use of a laminar flow hood to prepare PCR reaction mixtures is highly 24 
recommended to prevent contaminations 25 
2.4. Droplet-based microfluidic screening 26 
Microfluidic chips were molded into polydimethylsiloxane (PDMS) and electrodes were 27 
fabricated as described in [24]. 28 
2.4.1. Droplet digital PCR 29 
The libraries were diluted in 200 g/mL yeast total RNA solution (Ambion) to obtain the desired 30 
droplet occupancy. 1 µL of this dilution was then introduced in 100 L of PCR mixture containing 0.2 31 
M of Fwd-AmpliBarcode and Rev-add-ExtiSpi primers, 0.2 mM of each dNTPs (Fermentas), 10 M 32 
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Dextran-Texas Red 70 kDa (Molecular Probes), 0.1% Pluronic F68 (Sigma), 2 U of Q5 DNA 1 
polymerase (New England Biolabs) and the corresponding buffer at the recommended dilution.  2 
Critical point: Adding Pluronic F68 is critical to prevent unwanted adsorption of reagents 3 
(especially DNA) at the surface of the tubing or at inner droplet surface. 4 
The mixture was loaded into a length of PTFE tubing (Thermo) and infused into a droplet 5 
generator microfluidic chip where it was dispersed in 2.5 pL droplets carried by an HFE 7500 6 
fluorinated oil (3M) supplemented with 3% of a fluorosurfactant [25].  7 
Droplet production frequency (~ 12 000 droplets per second) was monitored in real time using an 8 
optical device and a software developed by the team [24] and used to determine droplet volume. 2.5 9 
pL droplets were generated by adjusting pumps flowrates (MFCS, Fluigent). The emulsion was 10 
collected into 0.2 mL tube and subjected to an initial denaturation step of 30 seconds at 95 °C followed 11 
by 30 PCR cycles of: 5 seconds at 95 °C, 30 seconds at 60 °C. 12 
 13 
2.4.2. Addition of in vitro expression mixture by droplet fusion 14 
PCR droplets were reinjected into a droplet fusion device at a rate of ~1500 droplets per second as 15 
described previously [24]. PCR droplets were spaced by a stream of HFE 7500 fluorinated oil (3M) 16 
supplemented with 2% (w/w) of a fluorosurfactant prior to being synchronized and paired one-to-one 17 
with a 16 pL in vitro transcription (IVT) droplet containing 2 mM of each NTP (Larova), 25 mM 18 
MgCl2, 44 mM Tris-HCl pH 8.0 (at 25°C), 50 mM KCl, 5 mM DTT, 1 mM Spermidine, 0.1% of 19 
Pluronic F68 (Sigma), 1 g of inorganic pyrophosphatase (Roche), 20 M DFHBI-1T (Lucerna), 0.5 20 
 of Dextran-Texas Red 70 kDa (Molecular Probes), 17.5 g/mL T7 RNA polymerase (purified in 21 
the laboratory) and optionally supplemented with 1 mM theophylline in the case of the positive 22 
selection.  23 
IVT mixture was loaded in a length of PTFE tubing and kept on ice during all the experiment and 24 
IVT droplets were produced using an HFE 7500 fluorinated oil (3M) stream supplemented with 2% 25 
(w/w). Flow-rates (MFCS, Fluigent) were adjusted to generate 16 pL IVT droplets and to maximize 26 
the synchronization of 1 PCR droplet with 1 IVT droplet. Pairs of droplets were then fused with an AC 27 
field (400 V at 30 kHz) and the resulting emulsion was collected off-chip in a tube prior to being 28 
incubated for 1 hour 30 minutes at 37°C. 29 
2.4.3. Droplet fluorescence analysis and sorting 30 
The emulsion was finally re-injected into an analysis and sorting microfluidic device [26] mounted 31 
onto a Thermo plate (Tokai Hit) holding the temperature at 37 °C. Droplets were infused at a 32 
frequency of ~ 200 droplets per second and spaced with a stream of surfactant-free HFE 7500 33 
fluorinated oil (3M). Green (DFHBI-1T in complex with competent fluorogenic aptamer) and orange 34 
(dextran Texas-Red) fluorescence of each droplet was analyzed. In rounds of positive selection (i.e. 35 
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performed in the presence of theophylline), the 1 to 10% greenest droplets displaying an orange 1 
fluorescence corresponding to single fused droplets were gated (Fig. S2). During the rounds of 2 
negative selection (i.e. performed in absence of theophylline), the ~ 25% dimmest green droplets 3 
displaying an orange fluorescence corresponding to single fused droplets were gated (Fig. S2). In both 4 
cases, gated droplets were deflected into collection channel by applying an AC field (1000 V 30 kHz) 5 
and collected into a 1.5 mL tube. Sorted droplets were recovered from the collection tubing by 6 
flushing 200 L of HFE 7500 fluorinated oil (3M). 100 L of 1H, 1H, 2H, 2H-perfluoro-1-octanol 7 
(Sigma-Aldrich) and 200 L of 200 g/mL yeast total RNA solution (Ambion) were then flushed and 8 
the droplets were broken by vortexing the mixture. DNA-containing aqueous phase was finally 9 
transferred a new tube.  10 
Critical point: the sequential addition of the three reagents (i.e. HFE 7500, 1H, 1H, 2H, 2H-11 
perfluoro-1-octanol and yeast total RNA) flushed through the collection tubing is important to 12 
maximize DNA recovery from the droplets. 13 
An aliquot (2 µL) of DNA-containing aqueous phase was treated as described in 2.3 to both 14 
amplify the material and reset the UDI carried by each molecule before using these molecules to prime 15 
a new round of screening.  16 
2.5. High-throughput sequencing and bioinformatic analysis 17 
Upon each round of screening, an aliquot of DNA-containing aqueous phase was prepared for 18 
Next Generation Sequencing analysis. In parallel, an aliquot of the starting library was treated the 19 
same way. 2 L of aqueous phase were introduced in a PCR mixture containing 0.2 M of both Fwd-20 
AmpliBarcode and Tag-iSpiTA-Lib-Theo  21 
(5-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTGTGTTCTCTGTCATCTCTCTG-3’) 22 
primers, 0.2 mM of each dNTP (Fermentas), 2 U of Q5 DNA polymerase (New England Biolabs) and 23 
the corresponding buffer at the recommended dilution. This mixture was subjected to an initial 24 
denaturation step of 1 minute at 98°C followed by 30 cycles of: 10 seconds at 98°C, 30 seconds at 25 
55°C and 30 seconds at 72°C. The recovered DNA was then indexed using Nextera Indexing kit 26 
(Illumina) following supplier recommendations. Finally, the indexed library was purified on a 1% 27 
agarose gel and the DNA recovered using a Monarch® purification kit (New England Biolabs). The 28 
quality of the DNA was then assessed on a Bioanalyzer (Agilent technologies) device and the DNA 29 
sequenced on MiSeq device (Illumina) using a V3-150 sequencing cartridge. 30 
Critical point: proper quantification of the library on a Bioanalyzer platform is critical to adjust 31 
the concentration of the DNA loaded on the sequencer and avoid over-clustering. 32 
Upon sequencing, 1 to 3 million reads were obtained for each library. Reads with a Q-score >30 33 
were then analyzed using a custom Python bioinformatic pipeline including 4 major steps (Fig. S3). 34 
First, identical sequences with the expected length were clustered together, and their occurrence 35 
measured. Second, an occurrence cut-off was manually set for each library (Fig. S4). Sequences with 36 
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an occurrence below that threshold were likely mutants (raised from PCR or sequencing errors) and 1 
were no longer considered for the rest of the analysis. Moreover, sequences displaying mutations 2 
outsides of randomized regions (i.e. the UDI and the communication module) were also filtered out. 3 
Third, counting the number of different UDIs associated with each “communication module” 4 
sequence, allowed for counting the number of droplets containing this particular sequence, so its 5 
occurrence. Finally, occurrence frequency of each sequence was computed and used to compute the 6 
enrichment factor (defined as the ratio of the occurrence frequency of the sequence after a given round 7 
over that in the starting library) of each sequence. All fastq files containing raw sequencing data 8 
generated in this study are available in the EMBL‐EBI European Nucleotide Archive [ENA: 9 
PRJEB31612]: http://www.ebi.ac.uk/ena/data/view/PRJEB31612. 10 
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2.6. Characterization of library responsiveness to theophylline 12 
An aliquot (1 L) of DNA-containing aqueous phase recovered at the end of each round of 13 
screening (or from the starting library) was amplified into 100 L of PCR mixture containing 0.1 M 14 
of Fwd-add-ExtiSpi and Rev-add-ExtiSpi primers, 0.2 mM of each dNTP (Fermentas), 0.05 U/µL Q5 15 
DNA polymerase (New England Biolabs) and the corresponding buffer at recommended 16 
concentration. The mixture was thermocycled with an initial denaturation step of 30 seconds at 95 °C 17 
followed by 25 repeats of the two-step cycle: 95 °C for 5 seconds and 60 °C for 30 seconds. PCR 18 
products were finally purified using a "Wizard® SV Gel and PCR Clean-up System " kit (Promega) 19 
and quantified with a Nanodrop (Thermo Scientific). 1.5 pmol of purified PCR product was 20 
introduced in an in vitro transcription (IVT) mixture containing 40 mM Tris-HCl pH 8.0, 22 mM 21 
MgCl2, 5 mM DTT, 1 mM Spermidine, 1.6 mM of each NTP, 20 M DFHBI-1T (Lucerna), 50 mM 22 
KCl, 5 ng/L inorganic pyrophosphatase (Roche), 1400 U T7 RNA polymerase (purified in the 23 
laboratory). Moreover, this mixture was optionally supplemented with 1 mM theophylline. The green 24 
fluorescence (ex: 492 nm/em: 516 nm) of activated DFHBI-1T was then monitored every minute for 2 25 
hours 30 minutes at 37°C on a real-time thermocycler (Mx 3005P, Agilent). 26 
2.7. Ligand sensing by purified RNA 27 
RNAs were synthetized and purified following the same protocol described in [23]. Prior to 28 
fluorescence measurement, purified RNAs were diluted in water and renatured by warming them 2 29 
minutes at 85°C prior to letting them cool at 25°C for 5 minutes. Then, 1 volume of renatured RNA (at 30 
desired concentration, herein 1 M) was added to 1 volume of a mixture containing: 80 mM Tris-HCl 31 
pH 8.0, 20 mM MgCl2, 20 M DFHBI-1T, 200 mM KCl and optionally 100 M of theophylline or 32 
another ligand (i.e. guanine, S-adenosyl methionine or c-di-GMP) for 1 hour at 25 °C. The green 33 
 8 
fluorescence (ex: 492 nm/em: 516 nm) was then monitored for 5 minutes at 25°C on a real-time 1 
thermocycler (Mx 3005P, Agilent). 2 
2.8. Affinity measurement 3 
Affinity between the biosensor and target ligands was determined by incubating 500 nM of the 4 
biosensor renatured using the same procedure described above (see §2.7) with 0.05 M to 100 M 5 
theophylline or caffeine in a mixture containing 40 mM Tris-HCl pH 8.0, 10 mM MgCl2, 10 M 6 
DFHBI-1T, 100 mM KCl. The green fluorescence (ex: 480 nm/em: 520 nm) of the activated DFHBI-7 
1T was then measured at room temperature on a real-time thermocycler (Mx 3005P, Agilent) and the 8 
KD was defined as the value of ligand leading to half the maximal fluorescence and was calculated by 9 
fitting the data to a Hill equation (OriginLab). 10 
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3. Results 12 
The goal of this work was to develop a fluorogenic RNA biosensor of theophylline using a 3-step 13 
methodology (Fig. 1B) in which: i) we designed and prepared a library of biosensors whom the CM 14 
region was randomized; ii) we screened this library in ultrahigh-throughput regime using the droplet-15 
based microfluidic pipeline we previously used to improve the function of ribozymes [24] and light-up 16 
aptamers [23, 27]; iii) we characterized the screening process using Next Generation Sequencing 17 
(NGS). 18 
3.1. Design of an iSpinach-based biosensor library 19 
We choose to start the development of our biosensor using iSpinach, an aptamer able the light-up 20 
the fluorogen DFHBI and its derivative DFHBI-1T [28] and improved for in vitro applications [23]. 21 
Indeed, we previously found that the molecule is endowed with very good folding properties, 22 
especially at the level of its basal stem [21]. Then, we weakened the structure of iSpinach apical helix 23 
by mutating the C38-G59 base pair located just above the DFHBI-binding pocket (Fig. 2 and Fig. S5). 24 
Introducing an A38-U59 base pair or deleting it had a severe effect on complex formation (Fig. S5). 25 
Conversely, using a U38-A59 pair led to a weak < 20% fluorescence reduction indicative of the 26 
expected structure weakening, while not compromising aptamer function. We next randomized two 27 
stretches of four nucleotides located directly on the top of the U38-A59 pair and connected them to the 28 
theophylline-binding aptamer (Fig. 2), a well characterized structure-switching aptamer [29, 30]. 29 
Randomizing stretches of four nucleotides made possible to explore a large sequence space, increasing 30 
therefore the likelihood to isolate an efficient communication module, while still being able to 31 
exhaustively screen the library with a good coverage (see below). Considering the current upper 32 
number of droplets (5 millions) that our technology allows to analyze per round and the reduced 33 
droplet occupancy (~ 10%) that one needs to use to limit multiple encapsulation events, using longer 34 
stretches of nucleotides would have compromised the possibility to exhaustively screen the starting 35 
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library. The molecule was flanked with constant regions later used as primer-binding sites for PCR 1 
amplification and one of these regions was further also flanked with the T7 RNA polymerase promoter 2 
sequence (Fig. S1). Finally, a random sequence of 20 nucleotides serving as Unique Droplet Identifier 3 
(UDI) was appended to the construct, upstream the transcription promoter. By analogy with the 4 
Unique Molecular Identifiers (UMIs) used to precisely establish transcript copy-number in 5 
transcriptomic analyses [31], here UDIs served to cluster together the genes coming from the same 6 
droplet and ultimately to count the number of droplets containing a given sequence upon sorting (see 7 
below).  8 
3.2. Ultrahigh-throughput screening 9 
The theophylline biosensor library was made of ~ 65,500 (48) different sequences and was 10 
exhaustively screened with a ~ 5-fold coverage using droplet-based microfluidics (Table S1). Briefly, 11 
each round of IVC screening consisted of 3 main steps (Fig. 1B). First, DNA molecules were diluted 12 
into a PCR mixture prior to being distributed into 2.5 pL water-in-oil droplets. Adjusting this dilution 13 
to have an average of 1 gene per 10 droplets, a value also known as  (here  was   Table S1) 14 
allowed limiting the rate of multiple encapsulation events. Indeed, since DNA molecules distribute 15 
into the droplets according to Poisson statistics [32], knowing  makes possible to precisely calculate 16 
the fraction of droplets initially occupied by one or more genes (less than 0.5 % at  ~ 0.1). Water-in-17 
oil droplets were then produced by infusing the aqueous phase into a microfluidic chip together with a 18 
fluorinated oil phase supplemented in a fluorosurfactant [25] allowing for stabilizing droplets and 19 
preventing their uncontrolled coalescence. Upon production, droplets were thermocycled to PCR-20 
amplify each gene into ~ 120,000 copies. Then, droplets were re-injected into a droplet fusion device 21 
[32] in which they were spaced by a stream of fluorinated oil (supplemented with 2% fluorosurfactant) 22 
and synchronized one-to-one with larger (16 pL) droplets generated on-chip and containing an in vitro 23 
transcription (IVT) mixture supplemented with DFHBI-1T as well as theophylline in case of positive 24 
selection (see below). Pairs of droplets were then fused together when passing between a pair of 25 
electrodes energized by an AC field. One-to-one pairing was maximized by monitoring the orange 26 
fluorescence of dextran-Texas Red added into both sets of droplets. Indeed, PCR droplets contained a 27 
high concentration (10 M) of dextran-Texas Red and were highly orange fluorescent. On the 28 
contrary, IVT mixture was supplemented with a low concentration (0.5 M) of dextran-Texas Red 29 
making the resulting droplets poorly orange fluorescent. However, upon droplet merging, fluorescence 30 
was expected to average, and a population of intermediate orange fluorescence appeared (Fig. S2). 31 
Using this strategy, it was possible to fuse more than 85% of IVT droplets mostly with one PCR 32 
droplet (Table S1). Upon fusion, droplets were collected and incubated for 1 hour 30 minutes at 37°C 33 
to allow the genes to be transcribed. Droplets were re-injected into a sorting device [26], in which they 34 
were spaced by a surfactant-free oil stream prior to getting their fluorescence analyzed. Those droplets 35 
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displaying an orange fluorescence corresponding to single-fused droplets as well as the expected green 1 
fluorescence from the DFHBI/aptamer complex were gated and specifically sorted from the bulk. 2 
Finally, upon sorting, droplets were broken, their DNA content recovered by PCR, their original UDI 3 
was exchanged for a new one to be able to track individual droplets during the next rounds and the 4 
process restarted.  5 
To select molecules able to efficiently activate DFHBI-1T fluorescence only in the presence of 6 
theophylline, we performed two rounds of positive selection (i.e. recovering those droplets highly 7 
fluorescent in the presence of theophylline) interspaced by three rounds of negative selection (i.e. 8 
recovering those droplets poorly fluorescent in the absence of theophylline) selections (Fig. 2). The 9 
efficiency of each round of screening was then assessed by in vitro transcribing libraries (the starting 10 
one and those enriched after the round) in the presence or in the absence of theophylline while 11 
monitoring DFHBI-1T fluorescence over the time (Fig. 2B). The first round of positive screening 12 
(round 1) allowed to significantly enrich the library in molecules able to activate DFHBI-1T 13 
fluorescence. However, the library also displayed a strong fluorescence in the absence of theophylline, 14 
indicating that a significant fraction of the aptamers activated DFHBI-1T in a theophylline-15 
independent manner. To further enrich the library in theophylline-responsive aptamers, we performed 16 
three rounds of negative selection in which the expression mixture was no longer supplemented in 17 
theophylline and we selected the non-fluorescent droplets (i.e. containing aptamer that do not activate 18 
DFHBI-1T in the absence of theophylline). Along these three rounds, the population progressively 19 
enriched in theophylline-responsive molecules. Indeed, whereas a high fluorescence was still observed 20 
in the presence of theophylline, almost no fluorescence was observed in the absence of the ligand (Fig. 21 
2B). To further enrich the library in highly fluorescent aptamers, we performed a last round of positive 22 
selection in the presence of theophylline. Computing the turn-on factor (defined as the ratio of the 23 
fluorescence in the presence over that in the absence of theophylline) allowed quantifying the 24 
responsiveness of each library and gave an overview of the screening process (Fig. 2C). We found that 25 
the value rapidly increased over the first rounds prior to reaching a plateau at round 4. We therefore 26 
stopped the screening process at round 5 and more deeply analyzed selected RNAs using high-27 
throughput sequencing. 28 
3.3. High-throughput sequence analysis 29 
Upon Illumina sequencing (MiSeq, V3-150 chemistry) of the different libraries (the starting 30 
library and the 5 enriched ones), reads were QC-filtered using a custom-made Python pipeline (Fig. 31 
S3). This process allowed to compute the enrichment of each sequence throughout the whole 32 
screening process (Fig. S6). 33 
This analysis allowed us to confirm that the starting library was properly randomized at each 34 
position since each nucleotide was found present at an equivalent frequency at each position (Fig. S7). 35 
After the first round of positive selection, more than 97 % of the sequence diversity was lost (diversity 36 
 11 
reduced from 65,536 to 1715 sequences, Fig. 3A), highlighting the great selection efficient of our 1 
microfluidic screening. This diversity kept on decreasing along the four next rounds to finally reach 2 
151 different sequences (0.23 % of the starting diversity) at the end of the process. As expected, the 3 
variants discarded between round 1 and 2 (Discarded R1 on Fig. 3C) displayed high fluorescence but 4 
were poorly responsive to theophylline. Higher responsiveness to theophylline was observed with 5 
variants discarded from round 4 but, as expected, these molecules tended to be dimmer than those 6 
conserved at the end of the process (round R5). Indeed, among all the aptamers tested, the five most 7 
abundant conserved after the fifth round displayed, in general, the best theophylline responsiveness 8 
(Fig. 3C). Interestingly, the 10 most abundant biosensors were also found to be continuously enriched 9 
throughout the different rounds (Fig. S6), indicating that they properly replied to each selection 10 
condition, an observation in agreement with their good general responsiveness to theophylline, 11 
whereas those less enriched sequences tend also to display a lower responsiveness to theophylline 12 
(Fig. S8). 13 
Finally, when looking closer at the sequence composition of the most enriched variants, we found 14 
a strong bias against C residues that were almost completely absent whereas Us represented at least 15 
half of the occurrences (Fig. 3D and Fig. S7). Therefore, the sensors tend to prefer communication 16 
module made of weak base pairs, with a strong preference for UG (or UU) pairs at the second and the 17 
third position. Interestingly, a similar preference for non-Watson-Crick base pairs and bias against 18 
strong GC base pairs was also described for the communications modules found in artificial on-switch 19 
aptazymes isolated in vitro [33] or in vivo [34], further reinforcing the conclusion of the present study. 20 
Moreover, similar sequence composition is also typically observed in thermosensor RNAs, a set of 21 
temperature-dependent structure switching RNA controlling gene expression [35, 36]. 22 
3.4. Functional validation of the theophylline biosensor 23 
The most abundant variant found at the end of our analysis had a communication module (5’-24 
AUUU-3’/5’-AUUU-3’) made of 2 non-canonical (UU) base pairs surrounded by 2 canonical (AU) 25 
ones. This sensor displayed a nice 5-fold activation amplitude in the presence of theophylline (Fig. S8) 26 
while preserving a good M-range affinity for theophylline and intact discrimination of caffeine (Fig. 27 
4A), a close homologue of theophylline. Interestingly, when looking at the ten most enriched variants, 28 
we found that the eighth most enriched variant displayed a very close sequence (5’-ACUU-3’/5’-29 
AUUU-3’) together with similar activation amplitude, affinity for theophylline and specificity (Fig. 30 
S9), suggesting that 5’-A(U/C)UU-3’/5’-AUUU-3’might be the optimal communication module for 31 
our construct. Even though they are efficient, both biosensors display affinities for theophylline an 32 
order of magnitude below that reported for the wild type theophylline aptamer [30]. Such a decrease 33 
can partly be explained by the exchange of the basal stem of the aptamer for a less stable 34 
communication module. Moreover, the use of a theophylline concentration (i.e. 1 mM) far exceeding 35 
the KD (320 nM) of the aptamer for its ligand did not allow to maintain a selection pressure for high 36 
 12 
affinity biosensors during the screening process. Therefore, one cannot rule out the possibility that 1 
biosensors of an even higher affinity could be selected using the same workflow but with lower 2 
concentration of theophylline. 3 
Moreover, to estimate to what extend the 5’-AUUU-3’/5’-AUUU-3’ communication module was 4 
universal, we tested several constructs in which the theophylline aptamer was exchanged for others 5 
known to specifically sense S-adenosyl methionine [37], guanine [37] or cyclic di-GMP [38, 39]. We 6 
were glad to observe that all the tested constructs were responsive to their cognate ligand (Fig. 4B), 7 
even though some constructs were less responsive. However, this was not surprising since a 8 
communication module is not a stand-alone element but, on contrary, it is embedded between two 9 
aptamers and, due to its function, it has to be sensitive to the sequences directly surrounding it. 10 
 11 
4. Conclusions 12 
In this work, we showed that droplet-based microfluidics could be used to screen aptamer-coding 13 
gene libraries by performing rounds of positive and negative selection. To the best of our knowledge, 14 
this is the first time that the successful development of a fluorogenic RNA biosensor is reported using 15 
such a high throughput. The possibility of quantitatively analyzing and sort millions of variants per 16 
day makes possible to exhaustively screen large libraries of molecules in which long regions were 17 
randomized. Moreover, characterizing selection products using NGS and bioinformatics further 18 
increase the efficiency of the method by making possible to track every sequence throughout the 19 
process and to rapidly identify those sequences enriching the best at each step, therefore those being 20 
very likely to be best adapted to the selection pressures, so having the wished properties. Whereas this 21 
work allowed isolating an efficient communication module (CM), this sequence was not completely 22 
universal, should a true universal CM (i.e. a CM optimally working in any possible sequence context) 23 
could really be developed. Consequently, the development of any new biosensor may need some 24 
refinement of the CM sequence to work optimally. However, the robustness of the present technology 25 
and its capacity to predict to some extend the best adapted molecules directly from sequencing data 26 
strongly reduces the experimental labor while providing deep information since every sequence 27 
permutation can be tested in a single set of experiments. It is noteworthy that the use of NGS for the 28 
characterization of selected nucleic acids already proved its efficiency when used in tandem with 29 
SELEX technology [40-42] as well as for the characterization of self-cleaving ribozymes (see the 30 
review by Yohei Yokobayashi in this issue [43]). This list of NGS-assisted analytical technologies of 31 
nucleic acids is therefore now completed by the technology we introduced in this work. Moreover, its 32 
application range is not limited to light-up aptamers as it can easily be extended to the selection of 33 
other structure-switching aptamer (e.g. riboswitches or aptazymes [44]) provided a fluorescence-based 34 
assay can be set-up. 35 
 36 
 37 
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Fig. 1. Principle and development of a fluorogenic RNA biosensor.  A. Working principle of a 2 
fluorogenic RNA biosensor. Upon detection of a target ligand (black circle) by the sensing domain 3 
(black), the information is transduced to the fluorogenic domain via the communication module 4 
(orange). As a consequence, the fluorogenic aptamer (in green) gets stabilized, recovers the capacity to 5 
bind its fluorogen (green circle) and forms a fluorescent complex. The G-quadruplex domain of 6 
iSpinach is outlined by squares.  B. Strategy proposed in this work for high-throughput development 7 
of RNA biosensors. A library is designed with a randomized communication module (orange) 8 
connecting a sensing aptamer to a fluorogenic one, herein iSpinach (in green). Mutations introduced to 9 
weaken the apical part of iSpinach are circled in red. The library is then subjected to a droplet-based 10 
microfluidic screening pipeline made of 3 major steps: digital droplet PCR (gene 11 
individualization/amplification), droplet fusion (gene expression) and droplet sorting (selection of 12 
droplets of interest) as described in [23]. The screening operates in two modes: i) either a positive 13 
selection in which the expression mixture is supplemented in theophylline and the fluorescent droplets 14 
are recovered or ii) a negative selection in which the expression mixture is free of theophylline and 15 
non-fluorescent droplets are recovered. Finally, all collected sequences are analyzed by Next 16 
Generation Sequencing (NGS) and bioinformatics. 17 
 18 
  19 
 18 
 1 
Fig. 2. Microfluidic-assisted functional screening of fluorogenic RNA biosensors of theophylline. A. 2 
Secondary structure of the RNA biosensors encoded by the gene library. The molecule is made of the 3 
theophylline specific aptamer (black) described in [30] linked via a randomized region of twice four 4 
nucleotides (orange) to a fluorogenic domain (green) derived from iSpinach [23]. Mutations 5 
introduced to weaken the apical part of iSpinach are circled in red, cst stands for constant region and 6 
Comm. module for Communication module. B. Responsiveness of the starting and the selected 7 
libraries to theophylline. The enrichment in functional fluorogenic RNA biosensor was monitored by 8 
monitoring in real-time the transcription of the library in presence (green line) or in absence (in black) 9 
of theophylline. Plots shadowed in dark green represent the profile of the libraries enriched upon a 10 
positive selection (in presence of theophylline). C. Turn-on capacity of the library along the screening 11 
process. The values were obtained from the ratio of the fluorescence in the presence over that in the 12 
absence of theophylline. The values are the mean of three independent experiments and error bars 13 
correspond to ± 1 standard error. 14 
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 2 
Fig. 3.  Sequence analysis of the starting and the enriched libraries. A. Sequence diversity of the 3 
communication modules. The number of different sequences found in the enriched libraries after each 4 
round of screening is given by the length of the both boxes. For each round the green box represents 5 
the number of sequences conserved at the end of the next round, whereas the discarded fraction is 6 
indicated by the orange box. Rounds in which positive selection was performed are indicated by the 7 
(+) whereas those where a negative selection was used are indicated by the (-). B. Enrichment 8 
progression throughout the screening process. The enrichment factor of the 151 communication 9 
modules isolated at the end of R5 was computed from the ratio of the occurrence frequency of the 10 
sequence in R1, R4 or R5 over that of the sequence in R0. The heatmap (expressed in Log10) 11 
summarizes the progression of this factor over the screening process. The sequence of the ten most 12 
abundant communication modules is given on the side of the heatmap. C. Biosensor responsiveness to 13 
theophylline. 500 nM of purified biosensor were incubated in presence of 10 M DFHBI-1T and 50 14 
M of theophylline (in green) or in the absence of theophylline (in black) at 25°C. Values are the 15 
mean of three independent experiments and error bars correspond to ± 1 standard error. D. Sequence 16 
composition of the ten most abundant biosensors isolated upon round 5. The global composition of 17 
each strand is shown as pie charts (top panel) and the composition at each position as a Logo 18 
representation (bottom panel). 19 
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Fig. 4. Functionality of the 5’-AUUU-3’/5’-AUUU-3’ communication module. A. Affinity and 2 
specificity of the most abundant variant (R5-1) possessing the 5’-AUUU-3’/5’-AUUU-3’ 3 
communication module. The RNA was gel purified and incubated with a range of concentration of 4 
theophylline or caffeine at 28°C and the fluorescence of the biosensor/DFHBI-1T complex was 5 
measured. A KD was measurable only for the theophylline (no signal observed in the presence of 6 
caffeine) and was calculated by fitting the data to a Hill equation. B. The sensing aptamer of R5-1 was 7 
exchanged for alternative aptamers sensing Guanine [37], S-adenosyl methionine [37] as well as two 8 
aptamer sensing c-diGMP and previously described by the group of Ming Hammond (MH) [39] and 9 
Jörg Hartig (JH) [38]. The RNA was incubated with 10 M DFHBI-1T and in the absence or in 10 
presence of 50 M of ligand prior to fluorescence measurement. The values are the mean of three 11 
independent experiments and error bars correspond to ± 1 standard error.   12 
